Introducing NEOGLY™, a novel body-worn QCL-based non-invasive continuous glucose monitoring device (NI-CGM). Developed under ISO 13485 regulation, it shows relevant glycemia predictions based on mid-infrared photoacoustic spectroscopy as well as AI-based algorithms fed by a digital twin that covers the entire detection chain including device modeling and human skin properties.